Terumo starts first US trial to assess red blood cells derived from pathogen-reduced whole blood – Medical Devices Business Review
May 1, 2018 @ 10:06

Terumo BCT has recruited first patient in the US clinical trial to assess the efficacy and safety of red blood cells derived from whole blood, which i…

Sourced through Scoop.it from: patientmonitoring.medicaldevices-business-review.com

Leave a Reply